Luminopia
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
955 Massachusetts Ave # 335, Cambridge, ...Phone Number
(857) 365-6636Website
www.luminopia.comRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About Luminopia
Luminopia, founded in 2016, is pioneering a new class of treatments for significant neuro-visual disorders. The company is dedicated to developing digital therapeutics that are both rigorously evaluated for FDA approval and engaging for patients. As an Innovation Partner of Boston Children's Hospital, Luminopia is advancing its lead product, Luminopia One, designed to improve vision in children with amblyopia, the leading cause of vision loss among children.Explore more
Luminopia Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Luminopia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Luminopia recently announced quarterly report
Check if Luminopia has recently received funding, and reach out quickly before it becomes old news!
Check out if Luminopia is spiking on competitors!
Luminopia, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Luminopia has new funding data
Congratulate Masked Content for being promoted to Masked Content at Luminopia
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Luminopia launches new products
Click to see if Luminopia had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Luminopia
Compare insights from companies similar to Luminopia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Luminopia is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Luminopia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Luminopia.
Luminopia financials insights
Gather financial insights about Luminopia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$10.5M
2023
Series A
$16M
Luminopia Tech Stack
Most Recent Scoops
Person-Based
Partnership, Medical Research
Person-Based
Partnership
Person-Based
Partnership, Patient Experience
Award
Award, Finance, Healthcare Technology
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Luminopia News & Media
Luminopia Announces First International Licensing Agreement with ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in Japan
Partnership expands global access to Luminopia's FDA-cleared lead product CAMBRIDGE, Mass., June 2, 2026 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with...Luminopia Shows Promise in Improving Control of Intermittent Exotropia in Pilot Study
FDA-cleared digital therapeutic demonstrates early evidence of improved eye movement control in children with intermittent exotropia CAMBRIDGE, Mass., March 25, 2026 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders,...Luminopia Announces CareFirst BlueCross BlueShield Coverage for Its Pediatric Lazy Eye Treatment
The policy further expands access to Luminopia's engaging, FDA-cleared treatment for children with lazy eye CAMBRIDGE, Mass., Feb. 25, 2026 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that...Luminopia Collaborates with Crunchyroll to Continue Building Its Extensive Content Library for Pediatric Lazy Eye Patients
Kids using Luminopia can now watch popular anime shows, further diversifying their content selection CAMBRIDGE, Mass., Oct. 28, 2025 /PRNewswire/ -- Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced a collaboration...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Luminopia
Sign Up For FreeTo access detailed company insights
Luminopia, founded in 2016, is pioneering a new class of treatments for significant neuro-visual disorders. The company is dedicated to developing digital therapeutics that are both rigorously evaluated for FDA approval and engaging for patients. As an Innovation Partner of Boston Children's Hospital, Luminopia is advancing its lead product, Lumino... Read More
